Table of Contents
ISRN Dermatology
Volume 2012 (2012), Article ID 863692, 6 pages
http://dx.doi.org/10.5402/2012/863692
Clinical Study

Effectiveness of Glycyrrhizinic Acid (Glizigen) and an Immunostimulant (Viusid) to Treat Anogenital Warts

1Hospital Clínico Quirúrgico Comandante Manuel Fajardo, Havana, Cuba
2Private Clic of dermatovenerologie, Svidnik, Slovakia

Received 21 March 2012; Accepted 3 May 2012

Academic Editors: E. Nagore and R. A. Schwartz

Copyright © 2012 José Domínguez Gómez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Douglas and J. A. E. Warts, Dermatología en Medicina General, Editorial Médica Panamericana, Buenos Aires, Argentina, 5ta edition, 2001.
  2. Z. L. Papiloma, http://www.facmed.unam.com.
  3. Consenso de Papiloma Virus Humano (HPV) y Herpes Simples Virus (HSV) Genital, http://www.sad.org.ar.
  4. M. Menéndez, M. D. L. Á. Hernández, O. A. vela de Oro, and A. Torres Chávez, “Actualización de la terapéutica del papilomavirus humano. Terapia convencional,” Revista Cubana de Medicina, vol. 43, no. 1, pp. 34–41, 2004. View at Google Scholar · View at Scopus
  5. O. E. F. Wincheids and A. L. Gonzáles , Condiloma Acuminado. Guías Clínicas en Atención primaria 2003, 3 (33), http://www.fisterra.com.br.
  6. Dirección Nacional de Estadísticas. MINSAP. Cuba, 2004.
  7. Centers for Disease Control and Prevention, “Guidelines for treatment of sexually transmitted diseases,” Morbidity and Mortality Weekly Report, vol. 51, no. RR06, pp. 1–80, 2002. View at Google Scholar
  8. P. E. Castle, S. Wacholder, A. T. Lorincz et al., “A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women,” Journal of the National Cancer Institute, vol. 94, no. 18, pp. 1406–1414, 2002. View at Google Scholar · View at Scopus
  9. E. De Clercq, “Therapeutic potential of HPMPC as an antiviral drug,” Reviews in Medical Virology, vol. 3, pp. 85–96, 1993. View at Google Scholar
  10. M. Favre, N. Ramoz, and G. Orth, “Human papillomaviruses: general features,” Clinics in Dermatology, vol. 15, no. 2, pp. 181–198, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. Centers for Disease Control and Prevention, Sexually transmitted diseases treatment guidelines 2002.MMWR, 51(No. RR-6):[53-57]http://www.cdc.gov/STD/treatment/.
  12. E. Van Cutsem, R. Snoeck, M. Van Ranst et al., “Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine,” Journal of Medical Virology, vol. 45, no. 2, pp. 230–235, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. H. Li, X. H. Gao, C. D. He, Z. Guomei, Z. X. Don, and H. D. Chan, “Detection of human papillomavirus and response to oral aratinoid ethylester in 2 cases of Darier disease,” Archives of Dermatology, vol. 137, pp. 695–696, 2001. View at Google Scholar
  14. F. X. Bosch, M. M. Manos, N. Muñoz et al., “Prevalence of human papilloma virus in cervical cancer: a worldwide perspective,” Journal of the National Cancer Institute, vol. 87, no. 11, pp. 796–802, 1995. View at Google Scholar
  15. D. Calisto and F. Arcangeli, “Topical cidofovir for condylomata acuminata of the genitalia in a 3-year-old child,” Journal of the American Academy of Dermatology, vol. 49, no. 6, pp. 1192–1193, 2003. View at Google Scholar · View at Scopus
  16. N. Muñoz, F. X. Bosch, S. de Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” The New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. F. T. Al-Gurairi, M. Al-Waiz, and K. E. Sharquie, “Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial,” British Journal of Dermatology, vol. 146, no. 3, pp. 423–431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Signore, “Candida immunotherapy of warts,” Archives of Dermatology, vol. 137, pp. 1250–1251, 2001. View at Google Scholar
  19. M. A. Mungía, Eficacia del ácido glicirricínico activado, con relación al nitrógeno líquido, y a la combinación de ambos, en el tratamiento del condiloma acuminado en pacientes atendidos en el Centro Nacional de Dermatología [Tesis de Especialista], Universidad Nacional Autonoma de Nicaragua, UNAN-Managua, 2006.
  20. Y. Soto, M. Mune, and A. Goicolea, “Aplicación de la técnica de reacción en cadena de la polimerasa para la detección de secuencias de Papillomavirus humano,” Revista Cubana de Medicina Tropical, vol. 50, no. 3, pp. 191–198, 1998. View at Google Scholar
  21. G. J. N. Sanabria, A. M. Mérida, S. V. Medina, and P. G. Valdés, 2004, Prevalencia del Papiloma Humano en el cuello uterino. Pinar del Río, http://www.conganat.org/7congreso/trabajo.asp?idtrabajo=495.
  22. R. Á. Sintes, Editorial Ciencias Médicas, vol. 2, no. 23, pp. 414–417, 2001.
  23. Ministerio de Salud Pública Colectivo de Autores, Infecciones de Transmisión Sexual, pautas para su tratamiento, Ministerio de Salud Pública, Ciudad Habana, Cuba, 2004.
  24. G. von Krogh, C. J. N. Lacey, G. Gross, R. Barrasso, and A. Schneider, “European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts,” Sexually Transmitted Infections, vol. 76, no. 3, pp. 162–168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Acevedo AS, Eficacia de la Podofilina, el Ácido tricloroacético y la Criocirugía en el Tratamiento de las Verrugas Genitales Externas [Tesis de Especialista], ISCM-H. Facultad Comandante Manuel Piti Fajardo, Ciudad Habana, Cuba, 2005.
  26. C. Miracco, N. Palummo, D. Lavergne, A. Nyongo, P. Tosi, and E.-M. de Villiers, “Malignant melanoma: search for human papillomavirus,” Archives of Dermatology, vol. 137, pp. 826–827, 2001. View at Google Scholar
  27. B. A. Luis, Estudio multicéntrico, prospectivo, abierto, controlado, sobre la eficacia, la seguridad clínica y la tolerabilidad local de la administración repetitiva (t.i.d.) por 5 días del ácido glicirricínico activado (Epigen) en pulverizaciones locales a pacientes cursando con herpes genital, Hospital General de México, Servicio de Infectología, Mexico City, México, 1997.
  28. I. I. Bogatyreva, Experience in Usage of EPIGEN at Treatment of Papilloma Virus Infection of the Urogenital Duct, Central Science—Research Institute of Dermatovenereal Diseases, City of Moscov, 2008.
  29. O. Martin-Crevillente, Report on the Results of the Tests with the Product Epigen (Laboratories Cheminova International, S.A., Madrid). Evaluate the Effectiveness and the Tolerance of the Antiviral Preparation Epigen in Women with Papillomavirus Infection, Ginecologic Center,“Salud y Mujer”, Madrid, Spain.
  30. A. Espinoza and L. Barragán, Estudio longitudinal, prospectivo, abierto, sobre la evaluación de la efectividad, la seguridad clínica y la tolerabilidad local de la administración repetitiva (q.id.) por 10 días del ácido glicirricínico activado (Epigén) en pulverizaciones locales a pacientes cursando con infección por virus del papiloma humano (HPV) a nivel del cérvix uterino, Clínica de Detección y Tratamiento de Displasias, Universidad de Guadalajara, Mexico City, México, 2004.
  31. H. Zelenková, A. Nejdková, E. Škutilová, M. Urbáni, D. Švecová, and J. Cabalová, “Preparations containing glycyrrhizic acid employed in dermatovenereologic practice. Conclusions of an international multicentre study,” Dermatologia Kliniczna, vol. 7, no. 3, pp. 135–139, 2005. View at Google Scholar · View at Scopus
  32. G. Andrews and A. Domonkos, “Enfermedades víricas,” in Tratado de Dermatología, p. 486, Editorial Médica Panamericana, 5ta edition, 2004. View at Google Scholar
  33. A. Rook, D. S. Wilkinson, F. J. Ebling, R. H. Champion, and J. Burton, Textbook of Dermatology, Blackwell Scientific, London, UK, 5fth edition, 1992.